How do doctors’ conversations differ from private to public social networks?Social Media in Pharma Share XHow do doctors’ conversations differ from private to public social networks?https://pharmaphorum.com/partner-content-digital/how-do-doctors-conversations-differ-from-private-to-public-social-networks/
What oncologists need from you when launching a new therapyAt the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is Share XWhat oncologists need from you when launching a new therapyhttps://pharmaphorum.com/partner-content/oncologists-need-launching-new-therapy/
Why doctors delay switching to new drugsIn the first of two articles, Theano Anastasopoulou uses behavioural economics to understand and investigate how physicians make Share XWhy doctors delay switching to new drugshttps://pharmaphorum.com/views-and-analysis/why-doctors-delay-switching-to-new-drugs/